Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumat ...
Abstract
Authors
T Takeuchi C Thorne G Karpouzas S Sheng W Xu R Rao K Fei B Hsu